Quarterly report · Q1
7446.TEDINET S100Q8CO
Period2022-10-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.4bn | 2022-10-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥37.3bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2021-10-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥254m | 2022-10-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥214m | 2021-10-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥271m | 2022-10-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥229m | 2021-10-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥271m | 2022-10-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥229m | 2021-10-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥182m | 2022-10-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥658m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥148m | 2021-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥187m | 2022-10-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥155m | 2021-10-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥19.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥17.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥18.1bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.5bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥10.8bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.7bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥202.31 | 2022-10-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥728.76 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥163.69 | 2021-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.6% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-10-01 → 2022-12-31 | ¥17m |
| Otherother segments | revenue external | 2022-10-01 → 2022-12-31 | ¥17m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2022-12-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2022-12-31 | ¥9.4bn |
| Otherother segments | revenue | 2021-10-01 → 2021-12-31 | ¥20m |
| Otherother segments | revenue external | 2021-10-01 → 2021-12-31 | ¥20m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥823m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥823m |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥3.8bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2021-12-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2021-12-31 | ¥9.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 58900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 58900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.061 | |
| Cash and deposits | Prior1YearInstant | 1407655000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 2376200000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 9413890000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 9752734000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 297093000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 429396000 | JPY |
| Merchandise | Prior1YearInstant | 1158309000 | JPY |
| Merchandise | CurrentQuarterInstant | 1307447000 | JPY |
| Lease investment assets ca | Prior1YearInstant | 123287000 | JPY |
| Lease investment assets ca | CurrentQuarterInstant | 124034000 | JPY |
| Other ca | Prior1YearInstant | 311112000 | JPY |
| Other ca | CurrentQuarterInstant | 321980000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -1750000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -53000 | JPY |
| Current assets | Prior1YearInstant | 12709597000 | JPY |
| Current assets | CurrentQuarterInstant | 14311741000 | JPY |
| Buildings and structures net | Prior1YearInstant | 480710000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 481882000 | JPY |
| Land | Prior1YearInstant | 1495006000 | JPY |
| Land | CurrentQuarterInstant | 1495006000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 135870000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 155528000 | JPY |
| Other net ppe | Prior1YearInstant | 329887000 | JPY |
| Other net ppe | CurrentQuarterInstant | 381706000 | JPY |
| Property plant and equipment | Prior1YearInstant | 2441474000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 2514122000 | JPY |
| Software in progress | Prior1YearInstant | 198245000 | JPY |
| Software in progress | CurrentQuarterInstant | 239022000 | JPY |
| Other ia | Prior1YearInstant | 8349000 | JPY |
| Other ia | CurrentQuarterInstant | 7864000 | JPY |
| Intangible assets | Prior1YearInstant | 206595000 | JPY |
| Intangible assets | CurrentQuarterInstant | 246887000 | JPY |
| Investment securities | Prior1YearInstant | 1433980000 | JPY |
| Investment securities | CurrentQuarterInstant | 1397427000 | JPY |
| Lease investment assets ioa | Prior1YearInstant | 110231000 | JPY |
| Lease investment assets ioa | CurrentQuarterInstant | 97273000 | JPY |
| Other ioa | Prior1YearInstant | 643409000 | JPY |
| Other ioa | CurrentQuarterInstant | 646665000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -25677000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -25639000 | JPY |
| Investments and other assets | Prior1YearInstant | 2161943000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 2115726000 | JPY |
| Noncurrent assets | Prior1YearInstant | 4810012000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 4876736000 | JPY |
| Assets | Prior1YearInstant | 17519610000 | JPY |
| Assets | CurrentQuarterInstant | 19188477000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |